187 related articles for article (PubMed ID: 34152098)
1. Screening and clinical significance of lymph node metastasis-related genes within esophagogastric junction adenocarcinoma.
Han R; Chen G; Li M; Peng ZM; Xu L
Cancer Med; 2021 Aug; 10(15):5088-5100. PubMed ID: 34152098
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of NFIA and NFIB in esophageal squamous carcinoma and esophagogastric junction adenocarcinoma.
Yang B; Zhou ZH; Chen L; Cui X; Hou JY; Fan KJ; Han SH; Li P; Yi SQ; Liu Y
Cancer Med; 2018 May; 7(5):1756-1765. PubMed ID: 29577671
[TBL] [Abstract][Full Text] [Related]
3. Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction.
Zhang X; Watson DI; Jamieson GG
Chin Med J (Engl); 2007 Dec; 120(24):2268-70. PubMed ID: 18167216
[TBL] [Abstract][Full Text] [Related]
4. Personalizing risk stratification by addition of PAK1 expression to TNM staging: improving the accuracy of clinical decision for gastroesophageal junction adenocarcinoma.
Li Z; Zou X; Xie L; Chen H; Chen Y; Yeung SC; Zhang H
Int J Cancer; 2015 Apr; 136(7):1636-45. PubMed ID: 25159681
[TBL] [Abstract][Full Text] [Related]
5. Extranodal metastasis is a powerful prognostic factor in patients with adenocarcinoma of the esophagogastric junction.
Zhang HD; Tang P; Duan XF; Chen CG; Ma Z; Gao YY; Zhang H; Yu ZT
J Surg Oncol; 2013 Dec; 108(8):542-9. PubMed ID: 24018956
[TBL] [Abstract][Full Text] [Related]
6. The Early Diagnostic Value of Serum Interleukin-8 in Esophagogastric Junction Adenocarcinoma.
Li Z; Xu H; Yu J; Liu C; Zheng C; Zeng R; Xu L; Li E; Peng Y; Xu Y
Cancer Control; 2021; 28():10732748211004883. PubMed ID: 33926265
[TBL] [Abstract][Full Text] [Related]
7. Optimal surgical management for esophagogastric junction carcinoma.
Matsuda T; Takeuchi H; Tsuwano S; Nakamura R; Takahashi T; Wada N; Kawakubo H; Saikawa Y; Omori T; Kitagawa Y
Gen Thorac Cardiovasc Surg; 2014 Sep; 62(9):560-6. PubMed ID: 24570201
[TBL] [Abstract][Full Text] [Related]
8. The prognostic significance of tumor ploidy and pathology in adenocarcinoma of the esophagogastric junction.
Schneeberger AL; Finley RJ; Troster M; Lohmann R; Keeney M; Inculet RI
Cancer; 1990 Mar; 65(5):1206-10. PubMed ID: 2302668
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the value of 7th editions of UICC-AJCC esophageal and gastric cancer TNM staging systems for prognostic prediction of adenocarcinoma of esophagogastric junction (Siewert type II)].
Shi GD; Luo ZL; Fu MY; Tian D; Zhang L; Zhang KP
Zhonghua Zhong Liu Za Zhi; 2014 Dec; 36(12):916-21. PubMed ID: 25623766
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
Hosokawa Y; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Daiko H; Nishimura M; Katsumata K; Sugiyama Y; Kinoshita T
Ann Surg Oncol; 2012 Feb; 19(2):677-83. PubMed ID: 21822549
[TBL] [Abstract][Full Text] [Related]
11. Tumors of the esophagogastric junction. Long-term survival in relation to the pattern of lymph node metastasis and a critical analysis of the accuracy or inaccuracy of pTNM classification.
Steup WH; De Leyn P; Deneffe G; Van Raemdonck D; Coosemans W; Lerut T
J Thorac Cardiovasc Surg; 1996 Jan; 111(1):85-94; discussion 94-5. PubMed ID: 8551792
[TBL] [Abstract][Full Text] [Related]
12. Status and prognosis of lymph node metastasis in patients with cardia cancer - a systematic review.
Okholm C; Svendsen LB; Achiam MP
Surg Oncol; 2014 Sep; 23(3):140-6. PubMed ID: 24953457
[TBL] [Abstract][Full Text] [Related]
13. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
[TBL] [Abstract][Full Text] [Related]
14. Lower mediastinal lymph node metastasis is an independent survival factor of Siewert type II and III adenocarcinomas in the gastroesophageal junction.
Nakamura M; Iwahashi M; Nakamori M; Naka T; Ojima T; Iida T; Katsuda M; Tsuji T; Hayata K; Mastumura S; Yamaue H
Am Surg; 2012 May; 78(5):567-73. PubMed ID: 22546130
[TBL] [Abstract][Full Text] [Related]
15. Comparison of mediastinal lymph node metastases from adenocarcinoma of the esophagogastric junction versus lower esophageal squamous cell carcinoma with involvement of the esophagogastric junction.
Mine S; Watanabe M; Kumagai K; Okamura A; Yuda M; Hayami M; Yamashita K; Imamura Y; Ishizuka N
Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 30791046
[TBL] [Abstract][Full Text] [Related]
16. Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma.
Yu JW; Zhang P; Wu JG; Wu SH; Li XQ; Wang ST; Lu RQ; Ni XC; Jiang BJ
J Exp Clin Cancer Res; 2010 Nov; 29(1):141. PubMed ID: 21054902
[TBL] [Abstract][Full Text] [Related]
17. Serum Insulin-Like Growth Factor Binding Protein 7 as a Potential Biomarker in the Diagnosis and Prognosis of Esophagogastric Junction Adenocarcinoma.
Liu CT; Xu YW; Guo H; Hong CQ; Huang XY; Luo YH; Yang SH; Chu LY; Li EM; Peng YH
Gut Liver; 2020 Nov; 14(6):727-734. PubMed ID: 31822054
[TBL] [Abstract][Full Text] [Related]
18. Adenocarcinomas of the esophagogastric junction: experiences at a single institution in China.
Zhang H; Wang W; Cheng Y; Song Y; Zhu K; Dang C
World J Surg Oncol; 2013 Jul; 11():155. PubMed ID: 23849250
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and Clinicopathological Significance of Lymph Node Metastasis in the Esophagogastric Junction Adenocarcinoma.
Urakawa N; Kanaji S; Suzuki S; Sawada R; Harada H; Goto H; Hasegawa H; Yamashita K; Matsuda T; Oshikiri T; Kakeji Y
Anticancer Res; 2022 Feb; 42(2):1051-1057. PubMed ID: 35093906
[TBL] [Abstract][Full Text] [Related]
20. Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma.
Xu YW; Chen H; Guo HP; Yang SH; Luo YH; Liu CT; Huang XY; Tang XM; Hong CQ; Li EM; Xu LY; Peng YH
Gastric Cancer; 2019 May; 22(3):546-557. PubMed ID: 30426295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
